|
|
Blood, 15 December 2005, Vol. 106, No. 13, pp. 4184-4190.
Prepublished online as a Blood First Edition Paper on September 1, 2005; DOI 10.1182/blood-2005-01-0226.
Previous Article | Next Article 
Submitted January 18, 2005
Accepted August 15, 2005
Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels
Piotr Religa*, Renhai Cao, Meit Bjorndahl, Zhongjun Zhou, Zhenping Zhu, and Yihai Cao
Laboratory of Angiogenesis Research, Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden
Department of Biochemistry, Faculty of Medicine, Laboratory Block L3-78, University of Hong Kong, Pokfulam, Hong Kong
ImClone Systems Incorporated, New York, NY, USA
* Corresponding author; email: piotr.religa{at}mtc.ki.se.
Bone marrow (BM)-derived circulating endothelial precursor cells (CEPCs) have been reported to incorporate into newly formed blood vessels under physiological and pathological conditions. However, it is unknown if CEPCs contribute to lymphangiogenesis. Here we show that in a corneal lymphangiogenesis model of irradiated mice reconstituted with enhanced green fluorescent protein (EGFP) positive donor bone marrow cells, CEPCs are present in the newly formed lymphatic vessels. Depletion of bone marrow cells by irradiation remarkably suppressed lymphangiogenesis in corneas implanted with FGF-2. Further, transplantation of isolated EGFP+/VEGFR-3+- or EGFP+/VEGFR-2+-cell populations resulted in incorporation of EGFP+ cells into the newly formed lymphatic vessels. EGFP+/CEPCs were also present in peritumoral lymphatic vessels of a fibrosarcoma. These data suggest that BM-derived CEPCs may play a role in 'lymphvasculogenesis'.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. K. Horst, T. Bickert, N. Brewig, P. Ludewig, N. van Rooijen, U. Schumacher, N. Beauchemin, W. D. Ito, B. Fleischer, C. Wagener, et al.
CEACAM1+ myeloid cells control angiogenesis in inflammation
Blood,
June 25, 2009;
113(26):
6726 - 6736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bogos, F. Renyi-Vamos, J. Dobos, I. Kenessey, J. Tovari, J. Timar, J. Strausz, G. Ostoros, W. Klepetko, H. J. Ankersmit, et al.
High VEGFR-3-positive Circulating Lymphatic/Vascular Endothelial Progenitor Cell Level Is Associated with Poor Prognosis in Human Small Cell Lung Cancer
Clin. Cancer Res.,
March 1, 2009;
15(5):
1741 - 1746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Conrad, H. Niess, R. Huss, S. Huber, I. von Luettichau, P. J. Nelson, H. C. Ott, K.-W. Jauch, and C. J. Bruns
Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo
Circulation,
January 20, 2009;
119(2):
281 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ichise, T. Ichise, O. Ohtani, and N. Yoshida
Phospholipase C{gamma}2 is necessary for separation of blood and lymphatic vasculature in mice
Development,
January 15, 2009;
136(2):
191 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Srinivasan, M. E. Dillard, O. V. Lagutin, F.-J. Lin, S. Tsai, M.-J. Tsai, I. M. Samokhvalov, and G. Oliver
Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature
Genes & Dev.,
October 1, 2007;
21(19):
2422 - 2432.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|